More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
Search
COVID-19 RCV thank you
A big thank you to all doctors, all nurses and all others working in the healthcare sector from the employees of BI Regional Centre Vienna. Read more here!
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Partnering for innovation and growth
In this interview Dr Frerich de Vries talks about why partnerships are one of the key areas of interest for Boehringer Ingelheim and more. Learn more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
COVID-19 Mentally strengthened through the Corona crisis
Our individual employee consultation offers employees several support options to manage the pandemic with strengthened mental health. Learn more.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
COVID-19 Learning from the pandemic
Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
Poultry Innovation Days 2018
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
Collaborating with RDA in the UK
The Riding for the Disabled Association (RDA) provides therapy, achievement and enjoyment to people with disabilities all over the UK. Learn more here.
Stroke
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
Poultry
We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here.
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
COVID-19 COVID-19 Southeast Asia Donations
Beyond direct support of the healthcare community on the ground, several organisations are receiving support in Southeast Asia & South Korea. Learn more.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Pets
We continuously innovate and expand our pet health solutions to address unmet needs. Click here to learn more about our work on pet health here.
COVID-19 Jordan medicine donations
Boehringer Ingelheim donates medicines in Jordan to support patients with chronic conditions. Click here to find out more about this support.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
Dr. V. Mohan Releases 9-point Action for People with Diabetes
Dr V. Mohan has released a 9-point action plan to ensure health for people with diabetes. Click here to read the press release and find out more.
Shanghai
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.